Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 17c; Guides FY13 Revs Below
Dolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.47, $0.17 better than the analyst estimate of $0.30. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
